Ceapro Inc V.CZO

Price action

[fossi_2002]

I don't think we'll see any increase in 1Q over the very strong 1Q 2022. My estimate is between 5-5.5 mill sales. However, I am sure we will see an increase in revenue during 2023. However, I do not see another sharp drop in share price towards mid40s. I rather think the stock market is already anticipating the worse Q1 numbers.
If I had more confidence in Gilles' abilities, I would say we are close to buy prices. But if the stock market already has no confidence in Gilles, why should shareholders have confidence in him? The AGM will show that the voices against Gilles have continued to grow. So far, I have not noticed anything of his announced "shareholderValue thoughts".

[prophetoffactz]

"I don't think we'll see any increase in 1Q over the very strong 1Q 2022. My estimate is between 5-5.5 mill sales. However, I am sure we will see an increase in revenue during 2023." Last year Q1 and Q2 were an anomaly in terms of annual revenue concentration. People should skip comparisons, in my opinion. The basic fact is that the business has been a ~10% grower for a decade